Molecular and Clinical Overview of Type 1 Neurofibromatosis: Single Center Study and Mini Review on NF1-Associated Vasculopathy and Juvenile Myelomonocytic Leukemia

Objective: Neurofibromatosis type 1 (NF1) is a genetic disorder presenting primary with variable patterns of skin pigmentation, neurofibromas and iris Lisch nodules. In addition, likely pathogenic/pathogenic mutations of the NF1 gene predispose to multiple tumors. Juvenile myelomonocytic leukemia (J...

Full description

Saved in:
Bibliographic Details
Main Authors: Şule Altıner, Alper Han Çebi
Format: Article
Language:English
Published: Galenos Publishing House 2024-10-01
Series:Gazi Medical Journal
Subjects:
Online Access:https://gazimedj.com/articles/molecular-and-clinical-overview-of-type-1-neurofibromatosis-single-center-study-and-mini-review-on-nf1-associated-vasculopathy-and-juvenile-myelomonocytic-leukemia/doi/gmj.2024.4241
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841526804332937216
author Şule Altıner
Alper Han Çebi
author_facet Şule Altıner
Alper Han Çebi
author_sort Şule Altıner
collection DOAJ
description Objective: Neurofibromatosis type 1 (NF1) is a genetic disorder presenting primary with variable patterns of skin pigmentation, neurofibromas and iris Lisch nodules. In addition, likely pathogenic/pathogenic mutations of the NF1 gene predispose to multiple tumors. Juvenile myelomonocytic leukemia (JMML) is also associated with NF1. Molecular diagnosis is important in patients with an atypical presentation, as well as in children who have not yet developed sufficient characteristic features or for providing prenatal diagnosis. The purpose of this study was to define NF1 gene mutations in the northeastern part of Türkiye and to contribute to the mutational spectrum of NF1. In addition, rare findings, such as cerebral vasculopathy and JMML, were discussed over the phenotypic findings. Methods: In this study, NF1 gene sequence analysis was performed using next-generation sequencing in 32 unrelated Turkish patients with a prediagnosis of NF1. Results: Disease-causing variants were found in 68.75% (n=22/32) of the patients, whereas two of them were novel. Our study was also important in the aspect of vasculopathy regarding the frequency which was 9.1% of in a relatively small patient group. Another aspect was the distinct distribution of malignant tumors. In contrast to central nervous system malignancies, which are the most common malignancies apart from malignant peripheral nerve sheath tumors in the literature, JMML was the most common in our study. Conclusion: The aim of this study is to draw attention to rare symptoms, such as vasculopathy and JMML, in NF1 in a small cohort. Although JMML is a rare childhood cancer, it is accompanied by RASopathies. It is important to investigate this association because JMLL treatment approaches change in the presence of germline mutations.
format Article
id doaj-art-67ba1f03e67545e7b9d7faf78d086a9b
institution Kabale University
issn 2147-2092
language English
publishDate 2024-10-01
publisher Galenos Publishing House
record_format Article
series Gazi Medical Journal
spelling doaj-art-67ba1f03e67545e7b9d7faf78d086a9b2025-01-16T11:01:34ZengGalenos Publishing HouseGazi Medical Journal2147-20922024-10-0135442243210.12996/gmj.2024.4241Molecular and Clinical Overview of Type 1 Neurofibromatosis: Single Center Study and Mini Review on NF1-Associated Vasculopathy and Juvenile Myelomonocytic LeukemiaŞule Altıner0https://orcid.org/0000-0001-5789-8630Alper Han Çebi1https://orcid.org/0000-0001-7388-874XDepartment of Medical Genetics, University of Health Sciences Türkiye, Trabzon Kanuni Training and Research Hospital, Trabzon, TürkiyeDepartment of Medical Genetics, Karadeniz Technical University Faculty of Medicine, Trabzon, TürkiyeObjective: Neurofibromatosis type 1 (NF1) is a genetic disorder presenting primary with variable patterns of skin pigmentation, neurofibromas and iris Lisch nodules. In addition, likely pathogenic/pathogenic mutations of the NF1 gene predispose to multiple tumors. Juvenile myelomonocytic leukemia (JMML) is also associated with NF1. Molecular diagnosis is important in patients with an atypical presentation, as well as in children who have not yet developed sufficient characteristic features or for providing prenatal diagnosis. The purpose of this study was to define NF1 gene mutations in the northeastern part of Türkiye and to contribute to the mutational spectrum of NF1. In addition, rare findings, such as cerebral vasculopathy and JMML, were discussed over the phenotypic findings. Methods: In this study, NF1 gene sequence analysis was performed using next-generation sequencing in 32 unrelated Turkish patients with a prediagnosis of NF1. Results: Disease-causing variants were found in 68.75% (n=22/32) of the patients, whereas two of them were novel. Our study was also important in the aspect of vasculopathy regarding the frequency which was 9.1% of in a relatively small patient group. Another aspect was the distinct distribution of malignant tumors. In contrast to central nervous system malignancies, which are the most common malignancies apart from malignant peripheral nerve sheath tumors in the literature, JMML was the most common in our study. Conclusion: The aim of this study is to draw attention to rare symptoms, such as vasculopathy and JMML, in NF1 in a small cohort. Although JMML is a rare childhood cancer, it is accompanied by RASopathies. It is important to investigate this association because JMLL treatment approaches change in the presence of germline mutations.https://gazimedj.com/articles/molecular-and-clinical-overview-of-type-1-neurofibromatosis-single-center-study-and-mini-review-on-nf1-associated-vasculopathy-and-juvenile-myelomonocytic-leukemia/doi/gmj.2024.4241neurofibromatosis type 1nf1cerebrovascular stenosisleukemiajmml
spellingShingle Şule Altıner
Alper Han Çebi
Molecular and Clinical Overview of Type 1 Neurofibromatosis: Single Center Study and Mini Review on NF1-Associated Vasculopathy and Juvenile Myelomonocytic Leukemia
Gazi Medical Journal
neurofibromatosis type 1
nf1
cerebrovascular stenosis
leukemia
jmml
title Molecular and Clinical Overview of Type 1 Neurofibromatosis: Single Center Study and Mini Review on NF1-Associated Vasculopathy and Juvenile Myelomonocytic Leukemia
title_full Molecular and Clinical Overview of Type 1 Neurofibromatosis: Single Center Study and Mini Review on NF1-Associated Vasculopathy and Juvenile Myelomonocytic Leukemia
title_fullStr Molecular and Clinical Overview of Type 1 Neurofibromatosis: Single Center Study and Mini Review on NF1-Associated Vasculopathy and Juvenile Myelomonocytic Leukemia
title_full_unstemmed Molecular and Clinical Overview of Type 1 Neurofibromatosis: Single Center Study and Mini Review on NF1-Associated Vasculopathy and Juvenile Myelomonocytic Leukemia
title_short Molecular and Clinical Overview of Type 1 Neurofibromatosis: Single Center Study and Mini Review on NF1-Associated Vasculopathy and Juvenile Myelomonocytic Leukemia
title_sort molecular and clinical overview of type 1 neurofibromatosis single center study and mini review on nf1 associated vasculopathy and juvenile myelomonocytic leukemia
topic neurofibromatosis type 1
nf1
cerebrovascular stenosis
leukemia
jmml
url https://gazimedj.com/articles/molecular-and-clinical-overview-of-type-1-neurofibromatosis-single-center-study-and-mini-review-on-nf1-associated-vasculopathy-and-juvenile-myelomonocytic-leukemia/doi/gmj.2024.4241
work_keys_str_mv AT sulealtıner molecularandclinicaloverviewoftype1neurofibromatosissinglecenterstudyandminireviewonnf1associatedvasculopathyandjuvenilemyelomonocyticleukemia
AT alperhancebi molecularandclinicaloverviewoftype1neurofibromatosissinglecenterstudyandminireviewonnf1associatedvasculopathyandjuvenilemyelomonocyticleukemia